Edinburgh scientists use engineered bacteria to
Author: Michael
How DLT’s chatbot turns fragmented public mark
Today we are lifting the lid on what this really
High-stakes debate and hackathon will probe brai
UT Health San Antonio readies for $38 million hu
Surprise cancelation of leading aging conference
Alchemab Therapeutics has appointed Ulrich Wendt,
Cellino has appointed Ed Tekeian as Chief Operati
Cognition Therapeutics presented an analysis from
Anavex Life Sciences presented new preclinical da